Structural Chemogenomics group, Laboratory of Therapeutic Innovation, UMR7200 CNRS-UdS (Université de Strasbourg), F-67400 Illkirch, France.
Curr Pharm Des. 2009;15(35):4026-48. doi: 10.2174/138161209789824786.
This review will focus on the construction, refinement, and validation of G Protein-coupled receptor models for the purpose of structure-based virtual screening. Practical tips and tricks derived from concrete modeling and virtual screening exercises to overcome the problems and pitfalls associated with the different steps of the receptor modeling workflow will be presented. These examples will not only include rhodopsin-like (class A), but also secretine-like (class B), and glutamate-like (class C) receptors. In addition, the review will present a careful comparative analysis of current crystal structures and their implication on homology modeling. The following themes will be discussed: i) the use of experimental anchors in guiding the modeling procedure; ii) amino acid sequence alignments; iii) ligand binding mode accommodation and binding cavity expansion; iv) proline-induced kinks in transmembrane helices; v) binding mode prediction and virtual screening by receptor-ligand interaction fingerprint scoring; vi) extracellular loop modeling; vii) virtual filtering schemes. Finally, an overview of several successful structure-based screening shows that receptor models, despite structural inaccuracies, can be efficiently used to find novel ligands.
这篇综述将聚焦于 G 蛋白偶联受体模型的构建、优化和验证,旨在进行基于结构的虚拟筛选。我们将介绍从具体建模和虚拟筛选实践中得出的实用技巧和窍门,以克服受体建模工作流程各个步骤相关的问题和陷阱。这些示例不仅将包括视紫红质样(A 类)受体,还将包括分泌素样(B 类)和谷氨酸样(C 类)受体。此外,该综述还将对当前晶体结构进行仔细的比较分析,并探讨其对同源建模的影响。我们将讨论以下主题:i)实验锚点在指导建模过程中的应用;ii)氨基酸序列比对;iii)配体结合模式适应和结合腔扩展;iv)跨膜螺旋中脯氨酸诱导的扭曲;v)基于受体-配体相互作用指纹评分的结合模式预测和虚拟筛选;vi)细胞外环建模;vii)虚拟筛选方案。最后,对几个成功的基于结构的筛选的概述表明,尽管受体模型存在结构上的不准确性,但它们可以有效地用于寻找新型配体。